(Total Views: 390)
Posted On: 11/26/2018 9:50:02 AM
Post# of 72446
I think Galera is waiting to see how the EOP2 meeting between IPIX and the FDA works out. They currently only have "1" clinical site open for their Phase3
testing of their "so-so" IV drug for OM.
They had 61 sites for 200 patients during P2. Now they are enrolling 335 patients for P3.
They may just throw in the towel after the IPIX EOP2 meeting.
Why waste all that money on nothing.
testing of their "so-so" IV drug for OM.
They had 61 sites for 200 patients during P2. Now they are enrolling 335 patients for P3.
They may just throw in the towel after the IPIX EOP2 meeting.
Why waste all that money on nothing.
(3)
(0)
